Fluorescence optical imaging of the breast has the potential to capture dynamic metabolic response signaling malignancy, according to a review published online Oct. 15 in Cancer Research.

Lightpoint Medical and Sagentia Technology and Product Development have been awarded a $200,000 grant by the U.K.’s Technology Strategy Board, the company announced earlier this month.

FDG uptake rose substantially in PET/CT scans of patients with higher levels of C-reative protein in their carotid arteries, pinpointing a potential biomarker for cardiovascular disease, according to an article published online Oct. 31 in the Journal of Nuclear Medicine.

Salvage patients, those with colorectal metastases to the liver who do not to respond to both first and second lines of treatment, are responding significantly to radioembolization with Y-90 microspheres. The dual-action treatment has been shown to lead to more than 12 months of overall survival, according to a study published Nov. 1 in the Journal of Nuclear Medicine.

Mention the term “workflow” and a common response is a roll of the eyes. That’s because the medical imaging facilities that have not yet achieved optimal workflow are experiencing extreme frustration while the facilities that have constructed reliable, systematic workflow are always looking for more.

It is International Day of Radiology Nov. 8 and radiological societies and institutions around the world are commemorating historical benchmarks and technological advancements in the field.

Over the past five years, leaders on both the clinical and business sides of radiology have learned the hard way that adaptability and flexibility are prized qualities required for survival.

In a comparison of gastrin-releasing peptide receptor (GRPR) bombesin analogs, F-18 aluminum flouride-labeled NODAGA-RM1 showed the most promise for PET imaging of prostate cancer, according to a study published online Nov. 6 in the Journal of Nuclear Medicine.